Xenon Xe 129 hyperpolarized

N/A

Report date: 2023/12/20 10:36:03
NME

Base Information

Drug NameXenon Xe 129 hyperpolarized
Drug Alias Name129Xe-MR129Xenon-MRIXenoview
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive
Global Approved IndicationsContrast agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/12/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPolarean Inc
China Registration ClassN/A

Develop Information

Active CompaniesPolarean IncUniversity Of Virginia
Inactive CompaniesN/A
Active IndicationsContrast agentsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A